[{"edinetCode":"E00987","stockCode":"4572","submitDate":"2018\/3\/29","endDate":"2017\/12\/31","numberOfEmployee":61.0,"averageTemporaryStaff":3.0,"sharesOwned":2067900.0,"sharesOwendPercent":0.2165,"numberOfSubsidiary":2.0,"bps":142.68,"equityRatio":0.622,"cashAndCashEquivalents":1856218000.0,"assets":2190386000.0,"currentAssets":2134250000.0,"fixedAsset":56136000.0,"tangibleFixedAssets":20381000.0,"intangibleFixedAssets":405000.0,"investmentAndOtherAssets":35349000.0,"liabilities":812477000.0,"currentLiabilities":341966000.0,"shorTermDept":null,"currentPortionOfBonds":28000000.0,"currentPortionOfLongTermDebt":153997000.0,"fixedLiabilities":470511000.0,"bonds":144000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":298122000.0,"netAsset":1377908000.0,"capitalStock":1364003000.0,"capital":3226487000.0,"capitalSurplus":2044512000.0,"accumulatedEarnings":-3906897000.0,"treasuryStock":-99000.0,"valuationAndConversionAdjustments":-1186000.0,"Sales":657516000.0,"costOfSales":222502000.0,"grossProfit":435013000.0,"sgaExpenses":1134074000.0,"salaryAndBenefit":123680000.0,"depreciationAndSGA":null,"RDExpenses":670861000.0,"operatingIncome":-699060000.0,"nonOperatingIncome":6587000.0,"nonOperatingExpenses":19023000.0,"interestExpense":6901000.0,"ordinaryProfit":-711496000.0,"extraordinaryGain":null,"extraordinaryLoss":21884000.0,"incomeBeforeTax":-733380000.0,"incomeTaxes":3883000.0,"netIncome":-737264000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-737264000.0,"comprehensiveIncome":-738967000.0,"eps":-78.53,"dilutedEps":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-561055000.0,"depreciationAndCashflowFromOperatingActivities":12114000.0,"cashFlowFromInvestingActivities":-38131000.0,"cashFlowFromFinancialActivities":295814000.0,"changesInCashAndCashEquivalents":-304967000.0,"previousYearAsset":2566295000.0,"previousYearSales":811598000.0,"previousYearNetIncome":-289940000.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"outstandingShares":9551300.0,"dividendPerShare":null,"grossProfit2":435014000.0,"grossProfitMargin":0.661602151,"operatingProfitMargin":-1.063183253,"recurringProfitRatio":-1.082096862,"SGAtoSalesRatio":1.724785404,"totalAssetTurnover":0.300182708,"currentRatio":6.241117538,"salesRateOfChange":-0.189850147,"netIncomeRageOfChange":1.542815755,"averageAssetsThisYear":2378340500.0,"totalAssetOrdinaryRateOfReturn":-0.299156492," totalAssetNetProfitMargin":-0.309990937,"totalAssetsNetProfitmarginAttributableToOwnersOfTheParentCompany":-0.309990937,"equityCapital":1362817000.0,"interestBearingDebt":624119000.0,"companyName":"カルナバイオサイエンス","industry":"医薬品"},{"edinetCode":"E00987","stockCode":"4572","submitDate":"2019\/3\/27","endDate":"2018\/12\/31","numberOfEmployee":62.0,"averageTemporaryStaff":2.0,"sharesOwned":2324700.0,"sharesOwendPercent":0.2293,"numberOfSubsidiary":1.0,"bps":86.83,"equityRatio":0.497,"cashAndCashEquivalents":1355254000.0,"assets":1770090000.0,"currentAssets":1671589000.0,"fixedAsset":98501000.0,"tangibleFixedAssets":18729000.0,"intangibleFixedAssets":183000.0,"investmentAndOtherAssets":79587000.0,"liabilities":882636000.0,"currentLiabilities":400139000.0,"shorTermDept":null,"currentPortionOfBonds":28000000.0,"currentPortionOfLongTermDebt":204814000.0,"fixedLiabilities":482497000.0,"bonds":116000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":337755000.0,"netAsset":887453000.0,"capitalStock":883563000.0,"capital":3591568000.0,"capitalSurplus":2409593000.0,"accumulatedEarnings":-5117482000.0,"treasuryStock":-117000.0,"valuationAndConversionAdjustments":-3326000.0,"Sales":754691000.0,"costOfSales":250699000.0,"grossProfit":503992000.0,"sgaExpenses":1648511000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1140841000.0,"operatingIncome":-1144519000.0,"nonOperatingIncome":1115000.0,"nonOperatingExpenses":15820000.0,"interestExpense":10628000.0,"ordinaryProfit":-1159223000.0,"extraordinaryGain":null,"extraordinaryLoss":47575000.0,"incomeBeforeTax":-1206799000.0,"incomeTaxes":3773000.0,"netIncome":-1210573000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1210573000.0,"comprehensiveIncome":-1212712000.0,"eps":-125.02,"dilutedEps":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1128026000.0,"depreciationAndCashflowFromOperatingActivities":12716000.0,"cashFlowFromInvestingActivities":-58314000.0,"cashFlowFromFinancialActivities":687522000.0,"changesInCashAndCashEquivalents":-500964000.0,"previousYearAsset":2190386000.0,"previousYearSales":657516000.0,"previousYearNetIncome":-737264000.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"outstandingShares":10139600.0,"dividendPerShare":null,"grossProfit2":503992000.0,"grossProfitMargin":0.667812389,"operatingProfitMargin":-1.516539882,"recurringProfitRatio":-1.536023353,"SGAtoSalesRatio":2.184352271,"totalAssetTurnover":0.426357417,"currentRatio":4.177520812,"salesRateOfChange":0.14779108,"netIncomeRageOfChange":0.641980349,"averageAssetsThisYear":1980238000.0,"totalAssetOrdinaryRateOfReturn":-0.585395796," totalAssetNetProfitMargin":-0.611327022,"totalAssetsNetProfitmarginAttributableToOwnersOfTheParentCompany":-0.611327022,"equityCapital":880237000.0,"interestBearingDebt":686569000.0,"companyName":"カルナバイオサイエンス","industry":"医薬品"},{"edinetCode":"E00987","stockCode":"4572","submitDate":"2020\/3\/27","endDate":"2019\/12\/31","numberOfEmployee":63.0,"averageTemporaryStaff":4.0,"sharesOwned":3413892.0,"sharesOwendPercent":0.293,"numberOfSubsidiary":1.0,"bps":329.86,"equityRatio":0.715,"cashAndCashEquivalents":4915056000.0,"assets":5376610000.0,"currentAssets":5274893000.0,"fixedAsset":101717000.0,"tangibleFixedAssets":29799000.0,"intangibleFixedAssets":234000.0,"investmentAndOtherAssets":71683000.0,"liabilities":1523088000.0,"currentLiabilities":1055162000.0,"shorTermDept":null,"currentPortionOfBonds":28000000.0,"currentPortionOfLongTermDebt":270972000.0,"fixedLiabilities":467926000.0,"bonds":88000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":341784000.0,"netAsset":3853522000.0,"capitalStock":3843543000.0,"capital":4657466000.0,"capitalSurplus":3475491000.0,"accumulatedEarnings":-4289192000.0,"treasuryStock":-222000.0,"valuationAndConversionAdjustments":-851000.0,"Sales":3207423000.0,"costOfSales":207590000.0,"grossProfit":2999833000.0,"sgaExpenses":2022055000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1281980000.0,"operatingIncome":977778000.0,"nonOperatingIncome":3282000.0,"nonOperatingExpenses":23900000.0,"interestExpense":8164000.0,"ordinaryProfit":957161000.0,"extraordinaryGain":null,"extraordinaryLoss":44101000.0,"incomeBeforeTax":913059000.0,"incomeTaxes":84770000.0,"netIncome":828289000.0,"netIncomeAttributableToOwnersOfTheParentCompany":828289000.0,"comprehensiveIncome":830764000.0,"eps":76.05,"dilutedEps":74.51,"per":27.9,"roe":0.351,"cashFlowFromOperatingActivities":1477773000.0,"depreciationAndCashflowFromOperatingActivities":9394000.0,"cashFlowFromInvestingActivities":-40945000.0,"cashFlowFromFinancialActivities":2121748000.0,"changesInCashAndCashEquivalents":3559801000.0,"previousYearAsset":1770090000.0,"previousYearSales":754691000.0,"previousYearNetIncome":-1210573000.0,"averageAge":44.1,"averageYearsOfService":7.7,"averageAnnualSalary":7294000.0,"outstandingShares":11654500.0,"dividendPerShare":null,"grossProfit2":2999833000.0,"grossProfitMargin":0.935278259,"operatingProfitMargin":0.304848472,"recurringProfitRatio":0.29842057,"SGAtoSalesRatio":0.630429787,"totalAssetTurnover":0.596551173,"currentRatio":4.999130939,"salesRateOfChange":3.249981781,"netIncomeRageOfChange":-1.684212352,"averageAssetsThisYear":3573350000.0,"totalAssetOrdinaryRateOfReturn":0.267860971," totalAssetNetProfitMargin":0.231796214,"totalAssetsNetProfitmarginAttributableToOwnersOfTheParentCompany":0.231796214,"equityCapital":3842692000.0,"interestBearingDebt":728756000.0,"companyName":"カルナバイオサイエンス","industry":"医薬品"},{"edinetCode":"E00987","stockCode":"4572","submitDate":"2021\/3\/26","endDate":"2020\/12\/31","numberOfEmployee":64.0,"averageTemporaryStaff":4.0,"sharesOwned":3168389.0,"sharesOwendPercent":0.2554,"numberOfSubsidiary":1.0,"bps":308.05,"equityRatio":0.79,"cashAndCashEquivalents":4299142000.0,"assets":4835356000.0,"currentAssets":4708193000.0,"fixedAsset":127162000.0,"tangibleFixedAssets":53330000.0,"intangibleFixedAssets":3613000.0,"investmentAndOtherAssets":70218000.0,"liabilities":1011346000.0,"currentLiabilities":727194000.0,"shorTermDept":null,"currentPortionOfBonds":28000000.0,"currentPortionOfLongTermDebt":161897000.0,"fixedLiabilities":284151000.0,"bonds":60000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":179887000.0,"netAsset":3824010000.0,"capitalStock":3830169000.0,"capital":558829000.0,"capitalSurplus":4310038000.0,"accumulatedEarnings":-1038476000.0,"treasuryStock":-222000.0,"valuationAndConversionAdjustments":-9709000.0,"Sales":1133346000.0,"costOfSales":192149000.0,"grossProfit":941196000.0,"sgaExpenses":1998264000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1474452000.0,"operatingIncome":-1057067000.0,"nonOperatingIncome":2749000.0,"nonOperatingExpenses":22778000.0,"interestExpense":7373000.0,"ordinaryProfit":-1077096000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":26390000.0,"incomeBeforeTax":-1102487000.0,"incomeTaxes":8545000.0,"netIncome":-1111032000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1111032000.0,"comprehensiveIncome":-1119890000.0,"eps":-90.33,"dilutedEps":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1260972000.0,"depreciationAndCashflowFromOperatingActivities":12410000.0,"cashFlowFromInvestingActivities":-70433000.0,"cashFlowFromFinancialActivities":724423000.0,"changesInCashAndCashEquivalents":-615914000.0,"previousYearAsset":5376610000.0,"previousYearSales":3207423000.0,"previousYearNetIncome":828289000.0,"averageAge":45.1,"averageYearsOfService":8.6,"averageAnnualSalary":6726000.0,"outstandingShares":12407100.0,"dividendPerShare":null,"grossProfit2":941197000.0,"grossProfitMargin":0.83045866,"operatingProfitMargin":-0.932695752,"recurringProfitRatio":-0.950368202,"SGAtoSalesRatio":1.763154412,"totalAssetTurnover":0.234387292,"currentRatio":6.474466236,"salesRateOfChange":-0.646649039,"netIncomeRageOfChange":-2.341357908,"averageAssetsThisYear":5105983000.0,"totalAssetOrdinaryRateOfReturn":-0.210947823," totalAssetNetProfitMargin":-0.217594144,"totalAssetsNetProfitmarginAttributableToOwnersOfTheParentCompany":-0.217594144,"equityCapital":3820460000.0,"interestBearingDebt":429784000.0,"companyName":"カルナバイオサイエンス","industry":"医薬品"},{"edinetCode":"E00987","stockCode":"4572","submitDate":"2022\/3\/25","endDate":"2021\/12\/31","numberOfEmployee":64.0,"averageTemporaryStaff":9.0,"sharesOwned":3744477.0,"sharesOwendPercent":0.2813,"numberOfSubsidiary":1.0,"bps":323.54,"equityRatio":0.793,"cashAndCashEquivalents":3817834000.0,"assets":5432560000.0,"currentAssets":5318487000.0,"fixedAsset":114073000.0,"tangibleFixedAssets":51574000.0,"intangibleFixedAssets":2738000.0,"investmentAndOtherAssets":59760000.0,"liabilities":1116988000.0,"currentLiabilities":774655000.0,"shorTermDept":null,"currentPortionOfBonds":28000000.0,"currentPortionOfLongTermDebt":211497000.0,"fixedLiabilities":342332000.0,"bonds":32000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":268390000.0,"netAsset":4315572000.0,"capitalStock":4291942000.0,"capital":1056953000.0,"capitalSurplus":4808163000.0,"accumulatedEarnings":-1572951000.0,"treasuryStock":-222000.0,"valuationAndConversionAdjustments":13789000.0,"Sales":2017529000.0,"costOfSales":135387000.0,"grossProfit":1882141000.0,"sgaExpenses":2413277000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1841854000.0,"operatingIncome":-531135000.0,"nonOperatingIncome":24315000.0,"nonOperatingExpenses":16172000.0,"interestExpense":3925000.0,"ordinaryProfit":-522992000.0,"extraordinaryGain":null,"extraordinaryLoss":9507000.0,"incomeBeforeTax":-532499000.0,"incomeTaxes":1975000.0,"netIncome":-534474000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-534474000.0,"comprehensiveIncome":-510976000.0,"eps":-42.1,"dilutedEps":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1536612000.0,"depreciationAndCashflowFromOperatingActivities":19164000.0,"cashFlowFromInvestingActivities":-41677000.0,"cashFlowFromFinancialActivities":1064987000.0,"changesInCashAndCashEquivalents":-481307000.0,"previousYearAsset":4835356000.0,"previousYearSales":1133346000.0,"previousYearNetIncome":-1111032000.0,"averageAge":45.1,"averageYearsOfService":9.1,"averageAnnualSalary":6337000.0,"outstandingShares":13313400.0,"dividendPerShare":null,"grossProfit2":1882142000.0,"grossProfitMargin":0.932894645,"operatingProfitMargin":-0.263260156,"recurringProfitRatio":-0.259224031,"SGAtoSalesRatio":1.196154801,"totalAssetTurnover":0.371377214,"currentRatio":6.865620179,"salesRateOfChange":0.780152751,"netIncomeRageOfChange":-0.518939148,"averageAssetsThisYear":5133958000.0,"totalAssetOrdinaryRateOfReturn":-0.101869162," totalAssetNetProfitMargin":-0.104105643,"totalAssetsNetProfitmarginAttributableToOwnersOfTheParentCompany":-0.104105643,"equityCapital":4305731000.0,"interestBearingDebt":539887000.0,"companyName":"カルナバイオサイエンス","industry":"医薬品"}]